Trusted by:
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published results of an expansive global review answering a basic scientific question, “How do you describe a ‘rare disease?’” in “Rare Disease Terminology and Definitions.”
ISPOR published a new Task Force Report, “Clinical Outcome Assessments (COAs): A Conceptual Foundation – Report of the ISPOR Clinical Outcomes Assessment Emerging Good Practices Task Force,” in Value in Health.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new Task Force Report, “Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force,” in the January/February 2016 issue of Value in Health (Volume 19, Issue 1).
ISPOR published a new Task Force Report, “Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force, ” in the March/April 2016 issue of Value in Health.
ISPOR has published its third Good Research Practices Task Force Report on preference-based methods that measure patient and other stakeholder preferences. The report appears in the June 2016 issue (Volume 19, Issue 4) of Value in Health.
ISPOR announced today the publication of an empirical study demonstrating that current Medicaid policies restricting hepatitis C treatment to patients with advanced disease are more costly and less effective than unrestricted, full-access strategies.
ISPOR announced the publication of a study comparing the metrics obtained from profile-case best-worst scaling (BWS) with those from a discrete choice experiment (DCE) with respect to hip replacement surgery. The study was published in the June 2016 issue of Value in Health.
ISPOR announced today the publication of a series of articles suggesting that the application of cost-effectiveness analysis for health care decision making in the US may be approaching critical mass. This special themed section was published in the July/August 2016 in Value in Health.
ISPOR's Medical Devices and Diagnostics Special Interest Group report, “Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations,” was published in the July/August 2016 issue (Volume 19, Issue 5) of Value in Health.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has published a new report, “Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report,” in the September/October 2016 issue of Value in Health.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right